{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:59:22Z","timestamp":1794715162961,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-468","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T11:03:17Z","timestamp":1409137397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study"],"prefix":"10.1186","volume":"14","author":[{"given":"Abate","family":"Assefa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baye","family":"Gelaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebeyaw","family":"Getnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gashaw","family":"Yitayew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"3767_CR1","volume-title":"Report on the Global AIDS Epidemic","author":"UNAIDS","year":"2010","unstructured":"UNAIDS: Report on the Global AIDS Epidemic. 2010, Geneva, Switzerland: UNAIDS"},{"key":"3767_CR2","volume-title":"Single Point HIV Prevalence Estimate","author":"The Federal HIV\/AIDS Prevention and Control Office","year":"2007","unstructured":"The Federal HIV\/AIDS Prevention and Control Office: Single Point HIV Prevalence Estimate. 2007, Ethiopia, Addis Ababa: Ministry of Health"},{"key":"3767_CR3","volume-title":"Global Tuberculosis Report 2013","author":"World Health Organization","year":"2013","unstructured":"World Health Organization: Global Tuberculosis Report 2013. 2013, Geneva, Switzerland: World Health Organization"},{"key":"3767_CR4","volume-title":"Tuberculosis, Leprosy and TB\/HIV Prevention and Control Program Manual","author":"Federal ministry of health","year":"2008","unstructured":"Federal ministry of health: Tuberculosis, Leprosy and TB\/HIV Prevention and Control Program Manual. 2008, Ethiopia, Addis Ababa: Ministry of Health"},{"issue":"5","key":"3767_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1590\/S0036-46652012000500004","volume":"54","author":"J Casseb","year":"2012","unstructured":"Casseb J, Fonseca LA, Medeiros LA, Gonsalez CR, Lagonegro ER, Veiga AP, da Silva DC, Mendon\u00e7a M, Duarte AJ: Tuberculosis among HIV-1-infected subjects in a tertiary out-patient service in S\u00e3o Paulo City, Brazil. Rev Inst Med Trop Sao Paulo. 2012, 54 (5): 257-259. 10.1590\/S0036-46652012000500004.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"3767_CR6","doi-asserted-by":"publisher","first-page":"e55824","DOI":"10.1371\/journal.pone.0055824","volume":"8","author":"A Gupta","year":"2013","unstructured":"Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD: Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS One. 2013, 8 (2): e55824-10.1371\/journal.pone.0055824.","journal-title":"PLoS One"},{"key":"3767_CR7","volume-title":"Implementation Guideline for TB\/HIV Collaborative Activities in Ethiopia","author":"Federal ministry of health","year":"2007","unstructured":"Federal ministry of health: Implementation Guideline for TB\/HIV Collaborative Activities in Ethiopia. 2007, Ethiopia, Addis Ababa: Ministry of Health"},{"key":"3767_CR8","volume-title":"Guidelines for Management of Opportunistic Infections and Anti Retroviral Treatment in Adolescents and Adults in Ethiopia","author":"Federal HIV\/AIDS Prevention and Control Office","year":"2007","unstructured":"Federal HIV\/AIDS Prevention and Control Office: Guidelines for Management of Opportunistic Infections and Anti Retroviral Treatment in Adolescents and Adults in Ethiopia. 2007, Ethiopia, Addis Ababa: Ministry of Health"},{"key":"3767_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1473-3099(06)70463-7","volume":"6","author":"M Battegay","year":"2006","unstructured":"Battegay M, N\u00fcesch R, Hirschel B, Kaufmann GR: Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis. 2006, 6: 280-287. 10.1016\/S1473-3099(06)70463-7.","journal-title":"Lancet Infect Dis"},{"key":"3767_CR10","doi-asserted-by":"publisher","first-page":"e17518","DOI":"10.1371\/journal.pone.0017518","volume":"6","author":"Z El-Khatib","year":"2011","unstructured":"El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L, Petzold M, Morris L, Ekstr\u00f6m AM: Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One. 2011, 6: e17518-10.1371\/journal.pone.0017518.","journal-title":"PLoS One"},{"issue":"135","key":"3767_CR11","first-page":"1000135","volume":"3","author":"I Eshun-Wilson","year":"2012","unstructured":"Eshun-Wilson I, Taljaard JJ, Nachega JB: Sub-optimal CD4 T-lymphocyte responses among HIV infected patients who develop TB during the first year of ART. AIDS Clin Res. 2012, 3 (135): 1000135-","journal-title":"AIDS Clin Res"},{"key":"3767_CR12","doi-asserted-by":"publisher","first-page":"e10527","DOI":"10.1371\/journal.pone.0010527","volume":"5","author":"SM Hermans","year":"2010","unstructured":"Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC: Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. PLoS One. 2010, 5: e10527-10.1371\/journal.pone.0010527.","journal-title":"PLoS One"},{"key":"3767_CR13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","volume":"20","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Myer L, Bekker LG, Wood R: Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006, 20: 1605-1612. 10.1097\/01.aids.0000238406.93249.cd.","journal-title":"AIDS"},{"key":"3767_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2334-12-66","volume":"12","author":"AB Andersen","year":"2012","unstructured":"Andersen AB, Range NS, Changalucha J, God GP, Kidola J, Faurholt-Jepsen D, Krarup H, Grewal HMS, Friis H: CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection. BMC Infect Dis. 2012, 12: 66-10.1186\/1471-2334-12-66.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"3767_CR15","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1086\/375346","volume":"187","author":"L Morris","year":"2003","unstructured":"Morris L, Martin DJ, Bredell H, Nyoka SN, Sacks L, Pendle S, Page-Shipp L, Karp CL, Sterling TR, Quinn TC, Chaisson RE: Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. J Infect Dis. 2003, 187 (12): 1967-1971. 10.1086\/375346.","journal-title":"J Infect Dis"},{"key":"3767_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/1471-2458-12-670","volume":"12","author":"M Brouwer","year":"2012","unstructured":"Brouwer M, Gudo PS, Simbe CM, Perdig\u00e3o P: The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique. BMC Public Health. 2012, 12: 670-10.1186\/1471-2458-12-670.","journal-title":"BMC Public Health"},{"key":"3767_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/jinf.2000.0721","volume":"41","author":"SJ Kony","year":"2000","unstructured":"Kony SJ, Hane AA, Larouz\u00e9 B, Samb A, Cissoko S, Sow PS, San\u00e9 M, Maynart M, Diouf G, Murray JF: Tuberculosis-associated severe CD4-T-lymphocytopenia in HIV-seronegative patients from Dakar. J Infect. 2000, 41: 167-171. 10.1053\/jinf.2000.0721.","journal-title":"J Infect"},{"issue":"4","key":"3767_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5493\/wjem.v2.i4.70","volume":"2","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Sugawara I: Immunology of tuberculosis. World J Exp Med. 2012, 2 (4): 70-74. 10.5493\/wjem.v2.i4.70.","journal-title":"World J Exp Med"},{"key":"3767_CR19","first-page":"211","volume":"4","author":"YA Melsew","year":"2013","unstructured":"Melsew YA, Terefe MW, Tessema GA, Ayele TA: Rate of immunological failure and its predictors among patients on highly active antiretroviral therapy at debremarkos hospital, northwest Ethiopia: a retrospective follow up study. J AIDS Clin Res. 2013, 4: 211-","journal-title":"J AIDS Clin Res"},{"key":"3767_CR20","volume-title":"Adult Antiretroviral Therapy in Resource Limited Settings: A Systematic Review of First-Line Failure and Attrition Rates","author":"F Renaud-Th\u00e9ry","year":"2008","unstructured":"Renaud-Th\u00e9ry F, Duncombe C, Kerr S, Thierry S, Perri\u00ebns J: Adult Antiretroviral Therapy in Resource Limited Settings: A Systematic Review of First-Line Failure and Attrition Rates. 2008, Geneva: World Health Organization"},{"key":"3767_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1742-6405-8-42","volume":"8","author":"N Khienprasit","year":"2011","unstructured":"Khienprasit N, Chaiwarith R, Sirisanthana T, Supparatpinyo K: Incidence and risk factors of antiretroviral treatment failure in treatment-na\u00efve HIV-infected patients at Chiang Mai University Hospital. Thailand AIDS Res Ther. 2011, 8: 42-10.1186\/1742-6405-8-42.","journal-title":"Thailand AIDS Res Ther"},{"issue":"1","key":"3767_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1468-1293.2007.00427.x","volume":"8","author":"P Srasuebkul","year":"2007","unstructured":"Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG: Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment. HIV Med. 2007, 8 (1): 46-54. 10.1111\/j.1468-1293.2007.00427.x.","journal-title":"HIV Med"},{"key":"3767_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1742-6405-6-17","volume":"6","author":"BK Kigozi","year":"2009","unstructured":"Kigozi BK, Sumba S, Mudyope P, Namuddu B, Kalyango J, Karamagi C, Odere M, Katabira E, Mugyenyi P, Ssali F: The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at joint clinical research centre, Uganda. AIDS Res Ther. 2009, 6: 17-10.1186\/1742-6405-6-17.","journal-title":"AIDS Res Ther"},{"key":"3767_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2334-6-59","volume":"6","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Myer L, Bekker LG, Wood R: CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis. 2006, 6: 59-10.1186\/1471-2334-6-59.","journal-title":"BMC Infect Dis"},{"key":"3767_CR25","first-page":"18757","volume":"16","author":"G Hirnschall","year":"2013","unstructured":"Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A: The next generation of the World Health Organization\u2019s global antiretroviral guidance. SJIAS. 2013, 16: 18757-","journal-title":"SJIAS"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-468\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T10:37:08Z","timestamp":1548239828000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3767"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-468","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]},"assertion":[{"value":"26 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"468"}}